| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 49,656 | 21,364 | ||
| Short-term investments | 66,294 | 117,643 | ||
| Accounts receivable, net | 2,334 | 2,183 | ||
| Inventory | 158 | 168 | ||
| Prepaid expenses and other current assets | 4,085 | 3,726 | ||
| Total current assets | 122,527 | 145,084 | ||
| Property and equipment, net | 1,981 | 2,132 | ||
| Goodwill | 44,543 | 44,543 | ||
| Operating lease right-of-use-assets | 7,508 | 4,456 | ||
| Restricted cash | 29,000 | 29,000 | ||
| Other assets | 368 | 368 | ||
| Total assets | 205,927 | 225,583 | ||
| Accounts payable | 3,797 | 5,899 | ||
| Accrued liabilities | 13,620 | 11,481 | ||
| Deferred revenue | 4,303 | 17,456 | ||
| Total current liabilities | 21,720 | 34,836 | ||
| Long-term debt, net | 56,508 | 56,107 | ||
| Other long-term liabilities | 7,540 | 5,200 | ||
| Total liabilities | 85,768 | 96,143 | ||
| Common stock, 0.001 par value 450,000,000 shares authorized 365,780,799 and 363,020,303 shares issued, respectively | 366 | 366 | ||
| Additional paid-in capital | 2,127,005 | 2,123,560 | ||
| Accumulated deficit | -2,002,054 | -1,989,285 | ||
| Accumulated other comprehensive (loss) income | 29 | -14 | ||
| Treasury stock, at cost, 2,381,939 and 1,528,008 shares, respectively | 5,187 | 5,187 | ||
| Total stockholders equity | 120,159 | 129,440 | ||
| Total liabilities and stockholders equity | 205,927 | 225,583 | ||
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)